Zura Bio Ltd financial data

Symbol
ZURA on Nasdaq
Location
La Jolla, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 766% % -8.2%
Debt-to-equity 16% % -4.1%
Return On Equity -50% % -14%
Return On Assets -40% % -20%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 65,023,308 shares -0.41%
Common Stock, Shares, Outstanding 65,018,058 shares -0.42%
Entity Public Float $206,282,986 USD -42%
Common Stock, Value, Issued $7,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 94,564,632 shares 8.3%
Weighted Average Number of Shares Outstanding, Diluted 94,564,632 shares 8.3%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $40,366,000 USD 83%
General and Administrative Expense $32,201,000 USD 14%
Operating Income (Loss) $72,567,000 USD -44%
Nonoperating Income (Expense) $7,467,000 USD 146%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $65,100,000 USD -38%
Net Income (Loss) Attributable to Parent $65,100,000 USD -38%
Earnings Per Share, Basic 0 USD/shares -142%
Earnings Per Share, Diluted 0 USD/shares -142%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $139,017,000 USD -26%
Assets, Current $142,292,000 USD -25%
Property, Plant and Equipment, Net $131,000 USD 198%
Other Assets, Noncurrent $1,512,000 USD 2808%
Assets $143,935,000 USD -24%
Accounts Payable, Current $3,275,000 USD 223%
Liabilities, Current $25,491,000 USD 40%
Liabilities $25,491,000 USD 40%
Retained Earnings (Accumulated Deficit) $207,372,000 USD -46%
Stockholders' Equity Attributable to Parent $108,243,000 USD -29%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $109,784,000 USD -29%
Liabilities and Equity $143,935,000 USD -24%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $11,063,000 USD -122%
Net Cash Provided by (Used in) Financing Activities $5,183,000 USD
Net Cash Provided by (Used in) Investing Activities $49,000 USD 99%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 65,018,058 shares -0.42%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $139,017,000 USD -26%
Deferred Tax Assets, Valuation Allowance $25,661,000 USD 43%
Deferred Tax Assets, Gross $25,661,000 USD 43%
Payments to Acquire Property, Plant, and Equipment $49,000 USD 600%
Deferred Tax Assets, Operating Loss Carryforwards $6,008,000 USD -14%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Additional Paid in Capital $315,608,000 USD 6.9%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $9,000 USD
Share-based Payment Arrangement, Expense $12,572,000 USD -23%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%